Single agents should be administered in preference to combination chemotherapy for the treatment of patients over 70 years of age with advanced ovarian carcinoma

Eur J Cancer. 2000 May;36(7):817-20. doi: 10.1016/s0959-8049(00)00050-2.
No abstract available

Publication types

  • Review

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Decision Making
  • Female
  • Humans
  • Ovarian Neoplasms / drug therapy*
  • Treatment Outcome

Substances

  • Antineoplastic Agents